| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 256.732 | 350.826 | 550.619 | 557.334 | 643.010 | 822.911 | 986.060 | 1.336.205 | 1.418.552 | 1.623.459 |
| Total Income - EUR | 256.762 | 352.930 | 550.647 | 557.337 | 643.149 | 822.987 | 995.084 | 1.363.561 | 1.418.591 | 1.638.886 |
| Total Expenses - EUR | 248.161 | 340.303 | 509.444 | 535.755 | 626.666 | 779.151 | 945.653 | 1.297.643 | 1.370.483 | 1.579.722 |
| Gross Profit/Loss - EUR | 8.602 | 12.627 | 41.203 | 21.582 | 16.483 | 43.836 | 49.431 | 65.918 | 48.107 | 59.165 |
| Net Profit/Loss - EUR | 6.799 | 10.016 | 34.382 | 15.971 | 10.009 | 37.307 | 41.055 | 57.137 | 40.222 | 49.954 |
| Employees | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 12 | 12 | 11 |
Check the financial reports for the company - Lotus Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.850 | 19.679 | 32.295 | 25.996 | 16.237 | 47.404 | 98.227 | 81.560 | 74.377 | 95.122 |
| Current Assets | 79.373 | 135.282 | 197.386 | 276.055 | 277.645 | 393.268 | 513.183 | 585.023 | 546.669 | 635.410 |
| Inventories | 48.376 | 80.936 | 105.231 | 148.988 | 141.391 | 217.627 | 317.773 | 361.762 | 317.022 | 355.715 |
| Receivables | 29.845 | 36.355 | 84.392 | 101.806 | 103.398 | 139.698 | 171.127 | 196.669 | 210.577 | 251.641 |
| Cash | 1.152 | 17.991 | 7.763 | 25.261 | 32.857 | 35.944 | 24.283 | 26.592 | 19.070 | 28.054 |
| Shareholders Funds | 11.952 | 10.069 | 44.281 | 59.440 | 68.298 | 73.714 | 85.612 | 134.961 | 98.756 | 148.158 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 74.594 | 145.407 | 185.850 | 243.199 | 225.892 | 367.975 | 526.387 | 532.689 | 525.860 | 585.614 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Lotus Pharma S.r.l.